News > Patients, Advocates, Researchers Come Together to Kick Cancer's KRAS

Patients, Advocates, Researchers Come Together to Kick Cancer's KRAS

Cancer patient advocates, researchers and pharmaceutical industry partners will be joining forces for the inaugural KRAS Kickers Connect conference.

"Until very recently," says Terri Conneran, KRAS Kickers Founder and Charlotte lung cancer patient/survivor, "the prognosis was dismal for cancer patients with the KRAS biomarker. Now, though, because of promising clinical trials and new therapeutics, we are celebrating the Pipeline of Hope for KRAS cancer patients with recent FDA approval of the first targeted therapy and more on the horizon."